Pierone G, Schulman KL, Fusco J, et al. Characteristics of Early Adopters of a Two-Drug Regimen (Dolutegravir/Rilpivirine) for Treatment of Human Immunodeficiency Virus Type 1 in the United States. Presented at: AMCP Managed Care & Specialty Pharmacy Annual Meeting 2019; San Diego, CA, USA
